Search research articles
Contact Us
Filters
Showing results (61-70 of 159) with videos related to
Page
of 16
Sort By:
Journal of the American Chemical Society
|
July 4, 2009
Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors
Jeffrey R Simard, Matthäus Getlik, Christian Grütter, et al.
Archiv Der Pharmazie
|
March 26, 2010
Proteus in the world of proteins: conformational changes in protein kinases
Matthias Rabiller, Matthäus Getlik, Sabine Klüter, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 19, 2016
Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR
Christian Becker, Sinan Öcal, Hoang D Nguyen, et al.
Journal of Medicinal Chemistry
|
April 24, 2014
Identification of type II and III DDR2 inhibitors
André Richters, Hoang D Nguyen, Trang Phan, et al.
Nature Chemical Biology
|
April 28, 2009
A new screening assay for allosteric inhibitors of cSrc
Jeffrey R Simard, Sabine Klüter, Christian Grütter, et al.
Journal of Medicinal Chemistry
|
June 9, 2012
Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase
Solveigh C Koeberle, Stefan Fischer, Dieter Schollmeyer, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2008
Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR
Anja Michalczyk, Sabine Klüter, Haridas B Rode, et al.
ACS Chemical Biology
|
January 24, 2007
Structure and properties of a re-engineered homeodomain protein-DNA interface
Matthew D Simon, Morris E Feldman, Daniel Rauh, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Displacement assay for the detection of stabilizers of inactive kinase conformations
Sabine Klüter, Christian Grütter, Tabassum Naqvi, et al.
Journal of Medicinal Chemistry
|
October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole blood
Benjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 159) with videos related to
Sort By:
Page
of 16
Journal of the American Chemical Society
|
July 4, 2009
Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors
Jeffrey R Simard, Matthäus Getlik, Christian Grütter, et al.
Archiv Der Pharmazie
|
March 26, 2010
Proteus in the world of proteins: conformational changes in protein kinases
Matthias Rabiller, Matthäus Getlik, Sabine Klüter, et al.
Chembiochem : a European Journal of Chemical Biology
|
March 19, 2016
Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR
Christian Becker, Sinan Öcal, Hoang D Nguyen, et al.
Journal of Medicinal Chemistry
|
April 24, 2014
Identification of type II and III DDR2 inhibitors
André Richters, Hoang D Nguyen, Trang Phan, et al.
Nature Chemical Biology
|
April 28, 2009
A new screening assay for allosteric inhibitors of cSrc
Jeffrey R Simard, Sabine Klüter, Christian Grütter, et al.
Journal of Medicinal Chemistry
|
June 9, 2012
Design, synthesis, and biological evaluation of novel disubstituted dibenzosuberones as highly potent and selective inhibitors of p38 mitogen activated protein kinase
Solveigh C Koeberle, Stefan Fischer, Dieter Schollmeyer, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2008
Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR
Anja Michalczyk, Sabine Klüter, Haridas B Rode, et al.
ACS Chemical Biology
|
January 24, 2007
Structure and properties of a re-engineered homeodomain protein-DNA interface
Matthew D Simon, Morris E Feldman, Daniel Rauh, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Displacement assay for the detection of stabilizers of inactive kinase conformations
Sabine Klüter, Christian Grütter, Tabassum Naqvi, et al.
Journal of Medicinal Chemistry
|
October 18, 2013
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole blood
Benjamin Baur, Kirsten Storch, Kathrin E Martz, et al.
Page
of 16